biotech

biotech

Sobi boosts gout battle with Arthrosi Therapeutics acquisition

biotech

Immune ‘switch’ is potential target to curb chronic inflammation in cirrhosis

biotech

InnoCare to move to phase 3 after achieving SLE endpoints

biotech

First precision therapy prostate cancer drug approved

biotech

FDA approves generalised myasthenia gravis drug

biotech

Breast cancer vaccine endpoints met with 74% immune response

biotech

Lilly to build $6bn Alabama facility

biotech

PsiThera unveiled with $47.5m funding to advance oral medicines